A 34 year old female with Cushing’s syndrome is taken for a surgery. Which anaesthetic agent is known to produce adrenocoical suppression?
**Core Concept**
Cushing's syndrome is a condition caused by excess levels of cortisol in the body, often due to a hormonal imbalance or tumor affecting the adrenal gland. Anesthetic agents can influence this delicate balance, and some may exacerbate or suppress adrenal function.
**Why the Correct Answer is Right**
Etomidate is a short-acting intravenous anesthetic agent known to inhibit 11-beta-hydroxylase, an enzyme crucial for cortisol production in the adrenal gland. By blocking this enzyme, etomidate leads to a decrease in cortisol levels, resulting in temporary adrenal insufficiency. This effect is particularly concerning in patients with pre-existing adrenal dysfunction, such as those with Cushing's syndrome.
**Why Each Wrong Option is Incorrect**
**Option A:** Propofol is a commonly used anesthetic agent, but it does not have a significant impact on adrenal function. Its mechanism of action involves enhancing inhibitory neurotransmission, not affecting cortisol production.
**Option B:** Midazolam is a benzodiazepine with sedative and anxiolytic properties, but it does not have a suppressive effect on the adrenal gland. Its primary mechanism is enhancing the effect of GABA in the brain.
**Option C:** Fentanyl is an opioid analgesic used for pain relief, but it does not influence adrenal function. Its mechanism involves binding to opioid receptors in the brain and spinal cord.
**Clinical Pearl / High-Yield Fact**
When managing patients with Cushing's syndrome or other adrenal disorders, it's essential to choose anesthetic agents that do not exacerbate their condition. Etomidate's effect on adrenal function should be carefully considered, and alternative agents may be chosen to minimize the risk of adrenal insufficiency.
**Correct Answer:** C. Etomidate.